Impulsive Penny Stocks - Soligenix Inc(OTCBB:SNGX), Volkswagen AG (ADR)(OTCMKTS:VLKAY), Decision Diagnostics Corp(OTCBB:DECN), Axa SA (ADR)(OTCMKTS:AXAHY)

Lewes, DE -- (SBWire) -- 09/30/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Soligenix Inc(OTCBB:SNGX), Volkswagen AG (ADR)(OTCMKTS:VLKAY), Decision Diagnostics Corp(OTCBB:DECN), Axa SA (ADR)(OTCMKTS:AXAHY).

Soligenix Inc(OTCBB:SNGX) ended lower -3.42% and complete the day at $2.26. The total number of shares changed hands during the day was 180,038. After opening at $2.36, the stock hit as high as $2.36. However, it traded between $0.37 and $2.48 over the last twelve months.

Soligenix, Inc., a development stage biopharmaceutical company, engages in developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents

Has SNGX Found The Bottom and Ready To Move Up? Find out via this report

Volkswagen AG (ADR)(OTCMKTS:VLKAY) closed yesterday at $46.13, a +0.20% increase. Around 33,549 shares were traded, low from an-average trading volume of 75,274 shares. The company is now valued at around $107.31 billion.

Volkswagen AG, together with its subsidiaries, engages in the manufacture and sale of automobiles worldwide. The company operates in four segments: Passenger Cars and Light Commercial Vehicles

For How Long VLKAY Gloss will Attract Investors? Find out via this report

Decision Diagnostics Corp(OTCBB:DECN) moved +13.48 percent higher at $0.800 and traded between $0.71 and $0.81 after opening the day at $0.72. Its performance over the last five days remained 12.68%, which stands at 344.44% for a month. Going back further than one month, 1-year performance after recent close was 300%.

Decision Diagnostics Corp. distributes prescription and non-prescription diagnostics, and home testing products in the United States. The company provides bulk prescription drugs on a wholesale basis; and distributes diabetes diagnostics and supplies

Will DECN Continue To Move Higher? Find Out Here

Axa SA (ADR)(OTCMKTS:AXAHY) shares rose, gaining +0.40 percent to close at $23.50. The stock is up around 28.98% this year and 57.72% for the last 12 months. Around 47,565 shares changed hands yesterday, lower from an-average trading volume of 100,680 shares.

AXA Group, through its subsidiaries, provides insurance and asset management services. Its Life & Savings segment offers term life, whole life, universal life, endowment, deferred and immediate annuities, and other investment-based products, including endowments and savings-related products, such as variable life and variable Annuity products

Why Should Investors Buy AXAHY After The Recent Gain? Just Go Here and Find Out

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/

Media Relations Contact

News Department
http://leadingstockalerts.com/

View this press release online at: http://rwire.com/343712